Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of Gabapentin Enacarbil (HORIZANT) Extended-Release Tablets for the Treatment of Alcohol Use Disorder
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2018
Price : $35 *
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 08 Mar 2017 Status changed from active, no longer recruiting to completed.
- 03 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 05 May 2016 According to a XenoPort media release, over 75% enrolment has been completed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA).